Vivos Therapeutics
Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical device company developing and commercializing oral appliance therapy systems for the treatment of craniofacial disorders including mild to moderate obstructive sleep apnea and other conditions associated with underdeveloped dental arches and airways in adults and children. According to its website at vivos.com, the company's Vivos System is a multi-disciplinary treatment approach combining proprietary oral appliances — worn in the mouth like orthodontic devices — with a coordinated clinical protocol that guides dental practitioners and sleep medicine physicians in treating the underlying anatomical causes of sleep-disordered breathing rather than simply managing symptoms. Unlike CPAP therapy — which requires nightly use of a pressurized mask to maintain airway patency — the Vivos System aims to create lasting improvement in airway dimensions by stimulating bone growth and remodeling in the maxilla and mandible, potentially reducing sleep apnea severity without ongoing nightly device use.
Vivos Therapeutics' Vivos System, described at vivos.com, utilizes proprietary removable oral appliances that apply controlled biomechanical forces to the dental arches and jaws during wear — stimulating the growth and remodeling of craniofacial bone structures to expand the upper and lower dental arches, create more space for the tongue, and improve upper airway dimensions that are restricted in patients with craniofacial underdevelopment associated with sleep apnea. The treatment protocol coordinates clinical management by trained dental practitioners — who fit and adjust the oral appliances — with sleep medicine physicians who diagnose and monitor the patient's sleep apnea severity throughout the treatment course. Vivos's multi-disciplinary approach requires training of dental practitioners and sleep medicine providers in the Vivos treatment protocol, which the company provides through its educational programs for healthcare professionals seeking to offer Vivos therapy to appropriate patients.
Vivos Therapeutics is listed on Nasdaq and pursues the commercialization of its oral appliance therapy system through the training and certification of dental and sleep medicine practitioners in the Vivos treatment approach, building a nationwide network of providers who can offer the Vivos System as a treatment option for appropriate sleep apnea patients. According to vivos.com, the company's educational and training programs for healthcare providers are central to its commercialization strategy, as the clinical effectiveness of the Vivos System depends on the skill and protocol adherence of the trained practitioners who fit and manage patients through treatment. Vivos Therapeutics' combination of craniofacial oral appliance system, sleep apnea treatment focus, multi-disciplinary clinical approach, Nasdaq-listed structure, and potential for lasting airway improvement through anatomical treatment rather than symptom management reflects its positioning as an innovative medical device company in the sleep medicine and orthodontic-adjacent craniofacial treatment market.